Application 080406
- Type
- ANDA
- Sponsor
- WEST-WARD PHARMS INT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.01MG/ML;1% | No | No |
| 002 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.01MG/ML;2% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A080406-001 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.01MG/ML;1% | INJECTABLE / INJECTION | RLD, Approved before 1982 | ||
| A080406-002 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.01MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | A080406-001 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | 0.01MG/ML;1% | INJECTABLE / INJECTION | Approved before 1982 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A080406-002 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | 0.01MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A080406-001 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | 0.01MG/ML;1% | INJECTABLE / INJECTION | Approved before 1982 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A080406-002 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | 0.01MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A080406-001 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | 0.01MG/ML;1% | INJECTABLE / INJECTION | RLD, Approved before 1982 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A080406-002 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | 0.01MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Cardinal Health 107, LLC | 77fd6ee4-108f-4525-8df5-7db9236042ee | 2026-05-20 | Warnings, Adverse reactions | Lidocaine Hydrochloride and Epinephrine |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Henry Schein, Inc. | 5569d607-f1cb-4f1d-8a00-d50433ec05d3 | 2026-05-07 | Warnings, Adverse reactions | Lidocaine Hydrochloride and Epinephrine |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Sportpharm LLC | 2c58deba-dbb2-4e73-a173-36053536f03e | 2026-04-22 | Warnings, Adverse reactions | Lidocaine Hydrochloride and Epinephrine |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Henry Schein, Inc. | c3490a23-14c4-43f7-b066-96a4c4298fde | 2026-04-14 | Warnings, Adverse reactions | Lidocaine Hydrochloride and Epinephrine |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | ProPharma Distribution | 43048b6b-3c83-eef4-e063-6294a90a34cb | 2025-12-18 | Warnings, Adverse reactions | Lidocaine Hydrochloride and Epinephrine |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Henry Schein, Inc. | e0e621d2-10b0-4cdf-b31d-c19b1e86ba6b | 2025-06-03 | Warnings, Adverse reactions | Lidocaine Hydrochloride and Epinephrine |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.